One-quarter of high risk patients denied anticoagulation after AF ablation

Very good long-term results for AF ablation across Europe:  The EORP Atrial Fibrillation Ablation Pilot Study reveals that 65% of patients were taking anticoagulants one year after ablation of AF. But up to 25% of patients at high risk of stroke (defined as a CHA2DS2-VASc score >1) were not taking any anticoagulant drug. And around half of patients with a low stroke risk (CHA2DS2-VASc score of 0) were still anticoagulated one year after the procedure.   Topics: Atrial Fibrillation
Source: ESC News and Press - Category: Cardiology Source Type: news